- €43.63bn
- €77.10bn
- €45.58bn
Federal judge sends Bayer's $7.25 billion Roundup settlement back to Missouri state court (updated)
Federal judge sends Bayer's $7.25 billion Roundup settlement back to Missouri state court
Brief: Bayer Completes Acquisition Of Perfuse Therapeutics
Brief: Bayer’s Ambelvist Receives FDA Approval For Contrast-Enhanced Mri To Detect And Visualize Lesions With Abnormal Vascularity In The Central Nervous System And Non-Cns Body Regions
Bayer hopes to speed up biofuel feedstock plan amid Iran war energy crunch
Brief: Bayer - European Medicines Agency Confirms Asundexian Marketing Authorization Application For Assessment In Secondary Prevention Of Ischemic Stroke
Brief: Phase III FIND‑CKD Results Show Bayer’s KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disease
In Roundup litigation, a funny thing is happening on the way to forum selection (updated)
Bayer says no plans to restructure despite litigation threat
Bayer drops as BofA says glyphosate Missouri class moved to California court
Refile: Bayer to challenge transfer of Roundup settlement case to California federal court
Bayer falls as US glyphosate settlement deadline nears
Column: In Roundup litigation, a funny thing is happening on the way to forum selection
Brief: Bayer AG Says Phase II Aracog Head-To-Head Trial Met Its Primary Endpoint
Bayer’s Monsanto debacle sows bitter M&A lessons
Europe Research Roundup: Bayer, Ceres Power Holdings, EasyJet
Bayer sued for allegedly monopolizing US market for GMO corn seeds
Bayer sued for allegedly monopolizing US market for GMO corn seeds
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo